Dexcom Wear and Learn

Take-Home Sensor Trial Program 


Experience offered at American Diabetes Association’s 2026 Scientific Sessions 

Gain direct experience and practical insights through real-world application.

Register for a free educational trial designed to give participants a unique, hands-on opportunity to experience Dexcom G7 15 Day and/or Stelo by Dexcom from the user perspective. Participants will receive a sensor to take home and explore personalized glucose insights through the in-app features.

Participation in this experience is first come, first served. Registration is required. Sensors must be taken off‑site for trial use. Application of the sensor is not permitted in the booth. 

When:
Friday, June 5 – Monday, June 8, 2026, open daily during conference exhibit hours 
 


Where:
Dexcom Booth #623
Register Today

Eligibility Information

Dexcom G7 15 Day 
Eligibility Requirements:
Participants must 
  • Be a prescriber with an active NPI number
  • Be licensed in the United States
  • Be an adult 18 years or older
  • Be unfamiliar with Dexcom G7 15 Day and need further education
  • Have a compatible smartphone

Stelo by Dexcom 
Eligibility Requirements:
Participants must 
  • Be a licensed healthcare professional—prescribing or non-prescribing—or a healthcare student
  • Be a resident of the United States
  • Be an adult 18 years or older not on insulin
  • Be unfamiliar with Stelo and need further education
  • Have a compatible smartphone

Side image
Prescribers licensed in the United States with an active NPI are eligible to trial both G7 15 Day and Stelo. Healthcare professionals licensed in Vermont are not eligible to participate.

This educational trial is exclusively for United States healthcare professionals and healthcare students. Industry participants are not eligible to participate. 

Please visit the registration page for eligibility requirements and terms & conditions.

Educational Resources

Build on your Take-Home Trial experience with resources to support getting started, interpreting data, and applying expert insights in clinical practice.   

Explore videos, workflow tools, and downloadable resources to support patient care. 

Access Glucose Tech
Side image

Questions?

If you have any questions, please contact Dexcom at events@dexcom.com
*Results with Dexcom CGM have been proven in over 70 clinical studies, data available on clinicaltrials.gov. † For Dexcom G7 compatible devices, visit dexcom.com/compatibility. For Stelo app compatibility information, visit stelo.com/compatibility. Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, Stelo, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries.

BRIEF SAFETY STATEMENT: Failure to use the Dexcom Continuous Glucose Monitoring System and its components according to the instructions for use provided with your device and available at https://www.dexcom.com/safety-information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the Dexcom CGM do not match symptoms, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency. 

MAT-13836